Resultados de la búsqueda 131-140 of 5175 for Anabolic

  1. Mayo Clinic Endocrinology Physician Update - December 2024

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review clinical records of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.